Anatara Lifesciences Ltd has released a press release.
Pause in Trading
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Appendix 4E & Financial Report 30 June 2025
- Anatara receives $969,455 in R&D Tax Incentive for FY25
- Hong Kong Patent Granted for GaRP
- Phase II GaRP-IBS Trial Internal Analyses of Data Subsets
- Funding Advance on R&D Refund
Later from Anatara Lifesciences
- Response to ASX Price Query
- Trading Halt
- Anatara receives firm commitments for $1.2m Placement
- Quarterly Activities/Appendix 4C Cash Flow Report
- Company Update
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences